Gastroenterology
Volume 139, Issue 3 , Pages 836-845.e1, September 2010

Genetic Covariance Between γ-Glutamyl Transpeptidase and Fatty Liver Risk Factors: Role of β2-Adrenergic Receptor Genetic Variation in Twins

Received 21 June 2009; accepted 1 June 2010. published online 10 June 2010.

Background & Aims

Plasma levels of γ-glutamyl transpeptidase (GGT) are associated with risk factors for nonalcoholic fatty liver disease (NAFLD), such as dyslipidemia, insulin resistance (IR), and hypertension. Limited data exist on whether there is genetic covariance between plasma levels of GGT and NAFLD risk factors. Variants of β2-adrenergic receptor gene (ADRB2) have been associated with dyslipidemia, IR, and hypertension, but its effect on GGT secretion is not known. We estimated the heritability of GGT using a twin-study design and examined the genetic covariance between GGT levels, IR, hypertension, levels of low-density lipoproteins and triglycerides, and ADRB2 variants.

Methods

We studied phenotypes of 362 twins; the heritabilities of increased GGT activity and genetic covariance with NAFLD risk factors were estimated by variance-component methodology. ADRB2 genotype associations with plasma GGT activity were examined using generalized estimating equations to account for intra-twinship correlations.

Results

GGT activity was heritable at 49% ± 8% of the twin cohort and had significant covariance with IR; insulin, triglyceride, and uric acid levels; and diastolic blood pressure. In generalized estimating equation models, the most common haplotype of ADRB2 was significantly associated with plasma GGT activity. Five single nucleotide polymorphisms in ADRB2 were associated with levels of GGT; ADRB2 haplotypes displayed pleiotropic effects on GGT and triglyceride levels.

Conclusions

In a twin study, GGT shared genetic codetermination with traits of metabolic syndrome. The ADRB2 gene had pleiotropic effects on plasma levels of GGT and triglycerides, indicating linked pathways (eg, adrenergic) between genetic susceptibility to NAFLD and metabolic syndrome.

Keywords: GGT, NAFLD, ADRB2, Metabolic Syndrome

Abbreviations used in this paper: ADRB2, β2-adrenergic receptor, BChE, butyryl-cholinesterase, BMI, body mass index, GEE, generalized estimating equation, GGT, γ-glutamyl transpeptidase, h2, heritability, HOMA, homeostasis model of insulin resistance, IR, insulin resistance, NAFLD, nonalcoholic fatty liver disease, SNP, single nucleotide polymorphism, ρE, rho-E (environmental covariance between traits), ρG, rho-G (genetic covariance between traits)

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 View this article's video abstract at www.gastrojournal.org

 Conflicts of interest The authors disclose no conflicts.

 Funding This work was supported in part by the National Institutes of Health grants to Daniel T. O'Connor, MD, and an American Gastroenterological Association Foundation, Sucampo, ASP Designated Research Scholar Award in Geriatric Gastroenterology (supported by a T. Franklin Williams Scholarship Award; Funding provided by: Atlantic Philanthropies, Inc, the John A. Hartford Foundation, the Association of Specialty Professors, and the American Gastroenterological Association) to Rohit Loomba, MD, MHSc. Role of funding agencies: Funding agencies did not have any role in the design and conduct of the study, collection, management, analysis and interpretation of the data; preparation, review, or approval of the manuscript.

PII: S0016-5085(10)00863-2

doi:10.1053/j.gastro.2010.06.009

Gastroenterology
Volume 139, Issue 3 , Pages 836-845.e1, September 2010